|
FI20011660A0
|
|
Medium support tray
|
|
FI20011157A0
|
|
Method for identifying assay excess in an immunological reaction
|
|
FI20002755A0
|
|
Method of therapy for erectile dysfunction
|
|
FI20002756A0
|
|
New treatment procedure
|
|
FI20002612A0
|
|
Combination therapy for the treatment of disorders in serotonin turnover
|
|
FI20002526A0
|
|
New use of pyridazinone derivatives
|
|
FI20002525A0
|
|
Anti-inflammatory substances
|
|
FI20002363A0
|
|
powder inhaler
|
|
FI20002215A0
|
|
Combination Particles
|
|
FI20002217A0
|
|
inhalation particles
|
|
FI20002216A0
|
|
Combination particles for asthma therapy
|
|
FI20002177A0
|
|
New combination for asthma therapy
|
|
FI20002044A0
|
|
Naphthalene derivatives which inhibit Comt enzymes
|
|
AU6573700A
|
|
Method for luminescence measurements
|
|
FI20001542A0
|
|
A method of treating septic shock
|
|
FI20000810A0
|
|
The powder inhaler
|
|
FI20000636A0
|
|
Care of disorders of the serotonergic system
|
|
FI20000635A0
|
|
Use of COMT inhibitors as an analgesic
|
|
FI20000480A0
|
|
Quinoline and naphthalene derivatives as alpha-2 antagonists
|
|
FI19991925A
|
|
Pharmaceutical solutions of levosimendan
|
